Evidence mapPaperPMID 41835459Full record

ArticleFrontiers in cardiovascular medicine2026

Intensive lipid-lowering therapy-related regression of a vulnerable plaque confirmed by serial optical coherence tomography: a case report.

Junru Qu, Kun Liu, Neil Johnson, Kenji Wagatsuma, Yingying Su, Beibei Du, Yuquan He

Abstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Junru Qu *Department of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.
Kun Liu *Department of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.
Neil JohnsonDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.
Kenji WagatsumaTsukuba Heart Center, Tsukuba Memorial Hospital, Ibaraki, Japan.
Yingying SuChangchun University of Chinese Medicine, Changchun, China.
Beibei DuDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.
Yuquan HeDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Acute coronary syndrome (ACS) remains a leading cause of mortality and disability worldwide. Vulnerable plaques constitute a key pathological substrate underlying ACS. Although lipid-lowering therapy (LLT) is central to plaque stabilization and secondary prevention in ACS, a substantial proportion of patients fail to achieve recommended lipid targets, underscoring a persistent gap between guideline recommendations and real-world outcomes. Serial assessment of plaque morphology using high-resolution intracoronary imaging may provide clinically actionable guidance for individualized management. Here, we report a case in which a ruptured coronary plaque in a patient with acute myocardial infarction underwent progressive healing, remaining phenotypically vulnerable at early follow-up before ultimately evolving into a stable plaque under intensive lipid-lowering and dual antiplatelet therapy, as documented by serial optical coherence tomography (OCT). Case presentation: A 52-year-old patient presented with acute chest pain and was diagnosed with ST-segment elevation myocardial infarction. Coronary angiography (CAG) and thrombus aspiration restored coronary flow, after which OCT evaluation was performed. A deferred stenting strategy was adopted, combined with intensive lipid-lowering therapy and dual antiplatelet therapy. At the 1-month follow-up, repeat CAG and OCT supported continued conservative management, and stent implantation was not performed. Over the subsequent year, the patient achieved sustained lipid control under close follow-up, without recurrent chest pain or other cardiac-related symptoms. Conservative management was continued without stent implantation. Serial OCT at 1 month and 1 year demonstrated a stepwise morphological transition of the culprit lesion: from an initially ruptured plaque to a healed but still vulnerable phenotype at early follow-up, and ultimately to a stable plaque phenotype at 1 year. Conclusion: Vulnerable plaques represent a principal pathological driver of acute coronary events. Sustained and effective LLT promotes plaque stabilization and regression, while serial OCT, owing to its high resolution and reproducibility, enables dynamic assessment of plaque morphology and supports individualized management in patients with ACS.

Indexed as

acute coronary syndromecase reportinclisiranlipid-lowering therapyvulnerable plaque

Identifiers

PMID41835459
PMCPMC12979529

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.